Abstract
There is general agreement among researchers, clinicians and patients that we need better treatments for chronic neuropathic pain. With the rapid advances in our understanding of genetics and molecular biology in the last 25 years there is renewed enthusiasm that better treatments can be developed. Considering the complexity of pain transmission at the molecular level described earlier in this book, not surprisingly, there are a large number of potential targets for the development of new drugs. It is not the goal of this chapter to provide a complete list of potential new drugs for treating chronic pain but rather to provide examples of the process of new drug development and of several promising new drugs.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
